Avastin® in Combination With Gemcitabine and Cisplatin Significantly Inhibits Tumor Angiogenesis and Increases the Survival Rate of Human A549 Tumor-Bearing Mice
Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2015.2402
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2015
Authors
Publisher
Spandidos Publications